Literature DB >> 29226177

Color discrimination errors associate with axial motor impairments in Parkinson's disease.

Nicolaas I Bohnen1,2,3,4, Jacob Haugen1, Andrew Ridder2,3, Vikas Kotagal2,3, Roger L Albin2,3,4, Kirk A Frey1,2, Martijn L T M Müller1,4.   

Abstract

BACKGROUND: Visual function deficits are more common in imbalance-predominant compared to tremor-predominant PD suggesting a pathophysiological role of impaired visual functions in axial motor impairments.
OBJECTIVE: To investigate the relationship between changes in color discrimination and motor impairments in PD while accounting for cognitive or other confounder factors.
METHODS: PD subjects (n=49, age 66.7±8.3 years; Hoehn & Yahr stage 2.6±0.6) completed color discrimination assessment using the Farnsworth-Munsell 100 Hue Color Vision Test, neuropsychological, motor assessments and [11C]dihydrotetrabenazine vesicular monoamine transporter type 2 PET imaging. MDS-UPDRS sub-scores for cardinal motor features were computed. Timed up and go mobility and walking tests were assessed in 48 subjects.
RESULTS: Bivariate correlation coefficients between color discrimination and motor variables were significant only for the Timed up and go (RS=0.44, P=0.0018) and the MDS-UPDRS axial motor scores (RS=0.38, P=0.0068). Multiple regression confounder analysis using the Timed up and go as outcome parameter showed a significant total model (F(5,43)= 7.3, P<0.0001) with significant regressor effects for color discrimination (standardized β=0.32, t=2.6, P=0.012), global cognitive Z-score (β=-0.33, t=-2.5, P=0.018), duration of disease (β=0.26, t=1.8, P=0.038), but not for age or striatal dopaminergic binding. The color discrimination test was also a significant independent regressor in the MDS-UPDRS axial motor model (standardized β=0.29, t=2.4, P=0.022; total model t(5,43)= 6.4, P=0.0002).
CONCLUSIONS: Color discrimination errors associate with axial motor features in PD independent of cognitive deficits, nigrostriatal dopaminergic denervation, and other confounder variables. These findings may reflect shared pathophysiology between color discrimination visual impairments and axial motor burden in PD.

Entities:  

Keywords:  Color discrimination; PET; Parkinson disease; dopamine; gait; postural instability; retina; visual

Year:  2017        PMID: 29226177      PMCID: PMC5716634          DOI: 10.1002/mdc3.12527

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  24 in total

1.  Abnormalities in color vision and contrast sensitivity in Parkinson's disease.

Authors:  M J Price; R G Feldman; D Adelberg; H Kayne
Journal:  Neurology       Date:  1992-04       Impact factor: 9.910

2.  Association of cognitive domains with postural instability/gait disturbance in Parkinson's disease.

Authors:  V E Kelly; C O Johnson; E L McGough; A Shumway-Cook; F B Horak; K A Chung; A J Espay; F J Revilla; J Devoto; C Wood-Siverio; S A Factor; B Cholerton; K L Edwards; A L Peterson; J F Quinn; T J Montine; C P Zabetian; J B Leverenz
Journal:  Parkinsonism Relat Disord       Date:  2015-04-14       Impact factor: 4.891

3.  Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations.

Authors:  Josie-Anne Bertrand; Christophe Bedetti; Ronald B Postuma; Oury Monchi; Daphné Génier Marchand; Thomas Jubault; Jean-François Gagnon
Journal:  Mov Disord       Date:  2012-11-12       Impact factor: 10.338

4.  Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease.

Authors:  A Ridder; M L T M Müller; V Kotagal; K A Frey; R L Albin; N I Bohnen
Journal:  Parkinsonism Relat Disord       Date:  2016-10-07       Impact factor: 4.891

5.  Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder.

Authors:  Ronald B Postuma; Anthony E Lang; Jessica Massicotte-Marquez; Jacques Montplaisir
Journal:  Neurology       Date:  2006-03-28       Impact factor: 9.910

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

7.  Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia.

Authors:  N I Bohnen; S Minoshima; B Giordani; K A Frey; D E Kuhl
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

8.  Heterogeneity of cholinergic denervation in Parkinson's disease without dementia.

Authors:  Nicolaas I Bohnen; Martijn L T M Müller; Vikas Kotagal; Robert A Koeppe; Michael R Kilbourn; Sid Gilman; Roger L Albin; Kirk A Frey
Journal:  J Cereb Blood Flow Metab       Date:  2012-05-09       Impact factor: 6.200

9.  Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.

Authors:  D Aarsland; K Brønnick; J P Larsen; O B Tysnes; G Alves
Journal:  Neurology       Date:  2008-11-19       Impact factor: 9.910

10.  Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease.

Authors:  Marie Y Davis; Catherine O Johnson; James B Leverenz; Daniel Weintraub; John Q Trojanowski; Alice Chen-Plotkin; Vivianna M Van Deerlin; Joseph F Quinn; Kathryn A Chung; Amie L Peterson-Hiller; Liana S Rosenthal; Ted M Dawson; Marilyn S Albert; Jennifer G Goldman; Glenn T Stebbins; Bryan Bernard; Zbigniew K Wszolek; Owen A Ross; Dennis W Dickson; David Eidelberg; Paul J Mattis; Martin Niethammer; Dora Yearout; Shu-Ching Hu; Brenna A Cholerton; Megan Smith; Ignacio F Mata; Thomas J Montine; Karen L Edwards; Cyrus P Zabetian
Journal:  JAMA Neurol       Date:  2016-10-01       Impact factor: 18.302

View more
  2 in total

Review 1.  Retinal Degeneration: A Window to Understand the Origin and Progression of Parkinson's Disease?

Authors:  Yanyan Zhang; Xiaoguang Zhang; Yunhua Yue; Tian Tian
Journal:  Front Neurosci       Date:  2022-02-04       Impact factor: 4.677

Review 2.  Management of Visual Dysfunction in Patients with Parkinson's Disease.

Authors:  Joseph Savitt; Rachid Aouchiche
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.